P63104 (1433Z_HUMAN) Homo sapiens (Human)

14-3-3 protein zeta/delta UniProtKBInterProSTRINGInteractive Modelling

245 aa; Sequence (Fasta) ; (Isoform 2); 97 identical sequences

Available Structures

65 Experimental Structures

DescriptionPDB IDOligo-stateRangeLigands
Structure of the MST4 and 14-3-3 complex
5xy9
 Heteromer
Q9P289; 		1-232
1×GOL; 1×PE4;
Assess
14-3-3 interaction with Rnd3 prenyl-phosphorylation motif
4bg6
 Heteromer
P61587; 		1-231
3×PE4; 2×FAR;
Assess
14-3-3 in complex with SARS-COV2 N phospho-peptide
7zit
 Heteromer
P0DTC9; 		1-230
2×ACT; 1×GOL; 1×BEZ;
Assess
14-3-3 zeta in complex with the human Son of sevenless homolog 1 (SOS1)
6f08
 Heteromer
Q07889; 		1-230
1×1PE;
Assess
Small-molecule stabilization of the 14-3-3/Gab2 PPI interface
5exa
 Heteromer
Q9UQC2; 		1-230
2×5SO; 2×BEZ; 1×MG;
Assess
Binary complex of 14-3-3 zeta Glucocorticoid Receptor (GR) pT524 peptide stabilised by (R)-para chl…
8a9g
 Heteromer
P04150; 		1-230
2×BTB; 2×QJK; 1×MG;
Assess
Molecular basis for the recognition of phosphorylated and phosphoacetylated histone H3 by 14-3-3
2c1n
 Heteromer
P68431; 		1-230
Assess
CRTC1 pSer151 peptide in complex with 14-3-3 zeta
7d8p
 Heteromer
Q6UUV9; 		1-230
1×GOL;
Assess
Binary complex of 14-3-3 zeta with Glucocorticoid Receptor (GR) pS617 peptide
6ymo
 Heteromer
P04150; 		1-230
1×SAL; 1×SO4;
Assess
Crystal structure of human 14-3-3 zeta in complex with PI4KIIIB peptide
5nas
 Heteromer
Q9UBF8; 		1-230
Assess
Binary complex of 14-3-3 zeta with Glucocorticoid Receptor (GR) pT524 peptide
6yo8
 Heteromer
P04150; 		1-230
Assess
Crystal structure of human 14-3-3 zeta in complex with CFTR R-domain peptide pS753-pS768
5d2d
 Heteromer
P13569; 		1-230
2×GLC; 4×CL;
Assess
Crystal structure of 14-3-3zeta in complex with a 8-carbon-linker cyclic peptide derived from ExoS
4n7y
 Heteromer
Q93SQ3; 		1-230
Assess
Human 14-3-3 isoform zeta in complex with a diphoyphorylated C-RAF peptide and Cotylenin A
4ihl
 Heteromer
P04049; 		1-230
2×K; 2×1F5;
Assess
CRTC1 pSer245 peptide in complex with 14-3-3 zeta
7d9v
 Heteromer
Q6UUV9; 		1-230
3×GOL;
Assess
Crystal structure of 14-3-3zeta in complex with a peptide derived from ExoS
4n7g
 Heteromer
Q93SQ3; 		1-230
10×P6G;
Assess
Small-molecule stabilization of the 14-3-3/Gab2 PPI interface
5ewz
 Heteromer
Q9UQC2; 		1-230
2×BEZ;
Assess
The molecular tweezer CLR01 stabilizes a disordered protein-protein interface
5m37
 Heteromer
P30307; 		1-230
4×9SZ; 2×BEZ;
Assess
Structure of 14-3-3 zeta in complex with ASK1 14-3-3 binding motif
6ejl
 Heteromer
Q99683; 		1-230
Assess
Crystal structure of 14-3-3zeta in complex with an alkyne cross-linked cyclic peptide derived from …
5j31
 Heteromer
Q93SQ3; 		1-230
1×BEZ;
Assess
Impaired binding of 14-3-3 to Raf1 is linked to Noonan and LEOPARD syndrome
3cu8
 Heteromer
P04049; 		1-230
2×MG; 1×PPI;
Assess
Impaired binding of 14-3-3 to Raf1 is linked to Noonan and LEOPARD syndrome
3nkx
 Heteromer
P04049; 		1-230
1×PPI;
Assess
Crystal Structure of 14-3-3 zeta with Chibby peptide
4wrq
 Heteromer
Q9Y3M2; 		1-230
Assess
CRTC1 pSer64 peptide in complex with 14-3-3 zeta
7d8h
 Heteromer
Q6UUV9; 		1-230
Assess
14-3-3 with peptide
6ef5
 Heteromer
Q96RR4; 		1-230
Assess
Crystal structure of 14-3-3zeta in complex with a 12-carbon-linker cyclic peptide derived from ExoS
4n84
 Heteromer
Q93SQ3; 		1-230
Assess
BRAF dimer bound to 14-3-3
6u2h
 Heteromer
P15056; 		1-230
2×29L;
Assess
14-3-3 protein zeta in complex with Thr758 phosphorylated integrin beta2 peptide
2v7d
 Heteromer
P05107; P63103; 		1-230
Assess
Molecular basis for the recognition of phosphorylated and phosphoacetylated histone H3 by 14-3-3
2c1j
 Heteromer
P68431; 		1-230
Assess
Binary complex of 14-3-3 zeta with Glucocorticoid Receptor (GR) pT524 pS617 peptide
6yos
 Heteromer
P04150; 		1-230
Assess
Structure of the LKB1 and 14-3-3 complex
5wxn
 Heteromer
Q15831; 		1-230
Assess
Apo BRAF dimer bound to 14-3-3
6xag
 Heteromer
P15056; 		1-230
1×EDO;
Assess
Dimeric (BRAF)2:(14-3-3)2 complex bound to SB590885 Inhibitor
7mff
 Heteromer
P15056; 		1-230
2×215;
Assess
Binary complex of 14-3-3 zeta with ubiquitin specific protease 8 (USP8) pSer718 peptide
6f09
 Heteromer
P40818; 		2-230
Assess
14-3-3 isoform zeta in complex with a diphoyphorylated C-RAF peptide
4fj3
 Heteromer
P04049; 		2-230
Assess
Crystal Structure of 14-3-3 zeta in Complex with a Serine 124-phosphorylated TBC1D7 peptide
5ulo
 Heteromer
Q9P0N9; 		1-229
2×EDO; 8×UNX; 2×LPD;
Assess
14-3-3-zeta in complex with S1011 phosphorylated integrin alpha-4 peptide
4hkc
 Heteromer
P13612; 		2-230
2×GOL;
Assess
The molecular tweezer CLR01 stabilizes a disordered protein-protein interface
5m35
 Heteromer
P30307; 		2-230
2×GOL; 2×BEZ;
Assess
The molecular tweezer CLR01 stabilizes a disordered protein-protein interface
5m36
 Heteromer
P30307; 		2-230
4×9SZ; 2×BEZ; 3×GOL;
Assess
Structure of 14-3-3 zeta in complex with CaMKK2 14-3-3 binding motif
6eww
 Heteromer
Q96RR4; 		1-229
Assess
Autoinhibited BRAF:(14-3-3)2:MEK complex with the BRAF RBD resolved
7mfd
 Heteromer
P15056; Q02750; 		2-230
2×ZN; 1×CHU;
Assess
Autoinhibited BRAF:(14-3-3)2 complex with the BRAF RBD resolved
7mfe
 Heteromer
P15056; 		2-230
2×ZN;
Assess
Structure of a MAPK pathway complex
6q0k
 Heteromer
P15056; 		2-230
Assess
Recognition of an intrachain tandem 14-3-3 binding site within protein kinase C epsilon
2wh0
 Heteromer
Q02156; 		2-229
1×PGE;
Assess
Crystal structure of human 14-3-3 zeta in complex with CFTR R-domain peptide pS753-pS768 and stabil…
5d3f
 Heteromer
P13569; 		2-229
1×FSC;
Assess
CRYSTAL STRUCTURE OF THE 14-3-3 ZETA:SEROTONIN N-ACETYLTRANSFERASE COMPLEX
1ib1
 Heteromer
Q29495; 		2-228
2×COT;
Assess
Crystal structure of 14-3-3[zeta]-LKB1 fusion protein
4zdr
homo-2-mer1-234
3×GOL; 2×SO4; 6×TME;
Assess
14-3-3 ZETA/PHOSPHOPEPTIDE COMPLEX (MODE 1)
1qjb
homo-2-mer1-232
Assess
Phosphorylation independent interactions between 14-3-3 and Exoenzyme S: from structure to pathogen…
2o02
homo-2-mer1-230
2×BEZ;
Assess
14-3-3 ZETA/PHOSPHOPEPTIDE COMPLEX (MODE 2)
1qja
homo-2-mer1-230
Assess
Mono- and bivalent 14-3-3 inhibitors for characterizing supramolecular lysine-PEG interactions in p…
6fna
homo-2-mer1-230
2×DWE; 2×BEZ; 2×CA; 4×CL; 2×GOL;
Assess
Mono- and bivalent 14-3-3 inhibitors for characterizing supramolecular lysine-PEG interactions in p…
6fnc
homo-2-mer1-230
2×DWK; 2×BEZ; 2×GOL; 2×CA; 4×CL;
Assess
Mono- and bivalent 14-3-3 inhibitors for characterizing supramolecular lysine-PEG interactions in p…
6fn9
homo-2-mer1-230
2×DW8; 2×BEZ; 2×GOL;
Assess
Mono- and bivalent 14-3-3 inhibitors for characterizing supramolecular lysine-PEG interactions in p…
6fnb
homo-2-mer1-230
2×BEZ; 3×GOL; 2×CA; 4×CL; 2×DWQ;
Assess
X-ray induced covalent inhibition of 14-3-3
3rdh
homo-2-mer1-230
2×3RD; 2×NI;
Assess
14-3-3 zeta chimera with 18E6 and fusicoccin
6zfg
homo-2-mer1-229
1×GOL; 2×FSC;
Assess
14-3-3 zeta bound to the phosphorylated 18E6 C-terminus
6zfd
homo-2-mer1-229
4×GOL;
Assess
Crystal structure of the chimera of human 14-3-3 zeta and phosphorylated cytoplasmic loop fragment …
8p1h
homo-2-mer1-229
4×EDO; 3×AZI; 1×BEZ; 1×PEG;
Assess
Crystal structure of 14-3-3zeta in complex with a cyclic peptide involving an adamantyl and a dicar…
5jm4
homo-2-mer1-229
2×BEZ;
Assess
Crystal Structure of 14-3-3zeta in complex with a macrocyclic 8-mer peptide derived from ExoS
6rlz
homo-2-mer2-230
Assess
Human 14-3-3 zeta fused to the BAD peptide including phosphoserine-74
7q16
homo-2-mer2-229
Assess
14-3-3 PROTEIN ZETA ISOFORM
1a4o
homo-2-mer1-228
Assess
Crystal structure of human 14-3-3 zeta fused to the NPM1 peptide including phosphoserine-48
8ah2
homo-2-mer2-229
Assess
14-3-3 PROTEIN ZETA BOUND TO R18 PEPTIDE
1a38
homo-2-mer1-228
Assess
14-3-3 PROTEIN ZETA BOUND TO PS-RAF259 PEPTIDE
1a37
homo-2-mer1-228
Assess

1 SWISS-MODEL model

TemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
7q16.1.Bhomo-2-mer0.822-241
93.36
Assess

1 SWISS-MODEL model built on isoform sequence

TemplateIsoformOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
Isoform 28ah2.1.Amonomer0.775-167
83.33
Assess